Healthcare: Is This Highly-Anticipated Gene Therapy In Trouble?
Industry Focus
The Motley Fool
4.6 • 854 Ratings
🗓️ 24 April 2019
⏱️ 22 minutes
🧾️ Download transcript
Summary
An infant participating in Novartis' Zolgensma trial has died, raising questions ahead of an expected FDA decision next month for this one-and-done treatment for spinal muscular atrophy. Here's what you should know. Also, why investors should ignore Intuitive Surgical's first quarter earnings miss and buy shares on sale.
Check out more of our content here:
Transcript
Click on a timestamp to play from that location
| 0:00.0 | This episode of Industry Focus is brought to you by Molecule. |
| 0:03.6 | Molecule is reimagining the future of clean air, |
| 0:07.0 | starting with the air purifier. |
| 0:09.3 | For $75 off your first order, visit M-O-L-E-K-U-L-E dot com and enter the promo code |
| 0:18.0 | full 75. |
| 0:22.0 | Welcome to Industry Focus, the show that dives into a different sector of the stock market every single day. |
| 0:28.0 | Today is Wednesday, April the 24th. |
| 0:31.0 | I'm your host Shannon Jones joined by foolish guru health care specialist |
| 0:36.4 | good guy all around Todd Campbell. Todd how are you? I'm good Shannon. |
| 0:42.0 | Hey Shannon you know what I really love? What is that? I love when like yes absolutely I love the show. I love when great companies go on sale. |
| 0:53.0 | Oh, I love it. |
| 0:55.4 | You're speaking my language here. |
| 0:56.5 | I love it. |
| 0:57.5 | And I love the fact that you brought that up |
| 0:59.7 | because that is really the first topic of today's show. We're going to be diving into a great company, |
| 1:06.0 | a full favorite that has gone on sale. We're going to be talking about what exactly is going on. |
| 1:11.4 | And then in the second half of the show, we've been keeping you up to date |
| 1:15.5 | on all the latest with gene therapy. We've got some news coming out of Novartis and |
| 1:20.9 | Vexis, so we'll be getting you all up to speed with that. But Todd let's dive right in to this this bargain |
| 1:28.0 | opportunity shares of intuitive surgical that is ticker Symbol, I S R G, the company behind the Da Vinci robotic system, |
| 1:38.0 | Saul shares plummet about 7% in after hours trading last Thursday. Todd, what was behind the drop? |
| 1:47.0 | You know, earnings season always gives you one or two really great opportunities to buy good stocks on sale. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.